Page 2 - முதுகெலும்பு அறுவை சிகிச்சை நிபுணர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Pilot project looks at improving motorcycle safety
rte.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rte.ie Daily Mail and Mail on Sunday newspapers.
Patient confuses brain tumor symptoms with depression, delays treatment
modernghana.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernghana.com Daily Mail and Mail on Sunday newspapers.
Doctors send letter to KCR, outline 20-point action plan for the state
deccanchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from deccanchronicle.com Daily Mail and Mail on Sunday newspapers.
KEYT
SAN LUIS OBISPO, Calif. - A breakthrough in spinal surgery is now available on the Central Coast through Tenet Health. This is an advancement of decades of surgical procedures, Orthopedic Spine Surgeon, Dr. James Carr said.
Back surgery no longer requires a 6 to 10 inch incision and a long hospital stay, according to Carr. He is the first surgeon in San Luis Obispo County to perform an Oblique Lumbar Inter-body Fusion. With this new minimally invasive procedure, people can get back home and on with their lives. If you re able to have a major spine surgery and go home that day or the next day! Carr said, It s definitely the future.
NEW DELHI - Doctors and experts say the government needs to improve its communication on drug safety amid concerns over the speedy approvals of vaccines, as well as glitches in a government app which resulted in only 64 per cent of intended recipients on the first two days of the nation s vaccine roll-out getting their shots.
The CoWIN app is being used by the government to alert recipients when it is their turn to get a shot.
India, which started vaccinations last Saturday (Jan 16), has approved two vaccines for emergency use: Covishield, developed by AstraZeneca and Oxford University, and Covaxin, developed by local firm Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).